Genetic defect found to cause disease in multiple organs

February 06, 2017

New research from Queen Mary University of London (QMUL) has identified a novel syndrome in patients with kidney and adrenal disease.

The research, published in the Journal of Clinical Investigation, identified defects in a novel gene called sphingosine-1-phosphate lyase (SGPL1) which causes multi organ disease particularly affecting the kidneys and adrenal glands. This may represent a novel lipid storage disorder similar to Niemann-Pick and Fabry disease, which are multi-systemic and progressive, often with neurological involvement.

The QMUL study involved patients from UK, Turkey, Pakistan, Spain and Peru and sequencing their DNA revealed the defective gene. Surprisingly, not all patients have the same symptoms, in some the kidney disease predominates and in others the adrenal dysfunction is the first symptom to emerge.

Lead researcher Dr Lou Metherell from QMUL's William Harvey Research Institute said: "The disease seems to be progressive, in some of our patients there has been a loss of motor and cognitive skills over time. Interestingly, the same gene defect has been linked to Charcot-Marie-Tooth neuropathy in another subset of patients.

"Getting a genetic diagnosis for these patients will allow for correct treatment, genetic counselling and careful monitoring to ensure any new symptoms are picked up early."

This study, which also involved QMUL researchers Rathi Prasad, Eirini Meimaridou, Helen Storr and Leo Guasti, highlights the importance of the sphingolipid pathway in adrenal and kidney function and suggests a potential role in other tissues such as the brain and thyroid.

The team found the main characteristics of the human disease occurred in mice with the same genetic defect, and could provide a useful model to test treatments for this devastating disorder.

Since strategies to modify SGPL1 activity are being explored in the treatment of conditions such as multiple sclerosis and rheumatoid arthritis, understanding what happens when it goes wrong may provide important insights into the long-term effects of altering this pathway in patients.
The study was funded by the Wellcome Trust and Medical Research Council.

More information

Research paper: 'Sphingosine-1-phosphate lyase (SGPL1) mutations cause primary adrenal insufficiency and steroid resistant nephrotic syndrome'. Journal of Clinical Investigation. Available here:

Queen Mary University of London

Related Kidney Function Articles from Brightsurf:

Cancer drug can rebalance kidney function in a devastating genetic disease
Researchers at the University of Cambridge and the University of Zurich have discovered that a drug newly approved for cancer improves kidney dysfunction in a mouse model of Dent disease 2 and Lowe syndrome

SphingoTec's kidney function biomarker penKid® accurately detects acute kidney injury in infants
penKidĀ® (Proenkephalin), a unique biomarker for the real-time assessment of kidney function.

Use of cystatin C for precise assessment of kidney function and cardiovascular risk
In many situations, it is essential that the physician knows a patient's kidney function as precisely as possible.

Young sugarcane workers at high risk of kidney function decline
Researchers from the Center for Health, Work and Environment (CHWE) at the Colorado School of Public Health have published a paper in PLoS-ONE, studying the decline in kidney function for young, first-time sugarcane workers in Guatemala.

Protein levels in urine after acute kidney injury predict future loss of kidney function
High levels of protein in a patient's urine shortly after an episode of acute kidney injury is associated with increased risk of kidney disease progression, providing a valuable tool in predicting those at highest risk for future loss of kidney function.

Kidney function may affect risks associated with prescription opioids
Compared with other pain medications, prescription opioids were linked with higher risks of death and hospitalization, particularly with higher doses.

Comparing major adverse cardiovascular events among patients with diabetes, reduced kidney function treated with metformin or sulfonylurea
This observational study compared major cardiovascular events (including hospitalization for heart attack, stroke, transient ischemic attack or cardiovascular death) among patients with diabetes and reduced kidney function treated with metformin or a sulfonylurea (a class of drugs to treat diabetes).

Fluoride may diminish kidney and liver function in adolescents, study suggests
luoride exposure may lead to a reduction in kidney and liver function among adolescents, according to a study published by Mount Sinai researchers in Environment International in August.

Higher kidney function at dialysis start linked with greater risk of death in children
In an analysis of information on children with kidney failure who began dialysis in the United States between 1995 and 2015, the risk of death was 1.36 times higher among children with higher kidney function at dialysis initiation.

Indigestion remedy slows kidney function decline and improves survival in late-stage CKD
As chronic kidney disease (CKD) progresses, the kidneys become less able to maintain a healthy balance of acids in the body.

Read More: Kidney Function News and Kidney Function Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to